Akers Logo Top Akers Biosciences  
Akers Logo Bottom
 
 
 
""


NEWS  

30 SEP  2009  Interim Results for the Six Months Ended 30 June 2009

Financial Summary: Gross margins increased by 18% over the same period
last year; Revenues totaled $1.18 million; Current assets in cash and cash
equivalents of $3.98 million; No debt.

 

29 SEP 2009  ABI signs Malaria Test Distribution Agreement

ABI announces an agreement with AFRICA Continental Holdings, LLC (“ACH”) to supply
rapid malaria tests for use initially in Ghana. Through this partnership, the Company will have access to various distributors with direct ties to government channels in Africa.

 

 

For additional information, please call +1 856 848 2116 or 1.800.451.TEST.

Government & Defense Procurement Information

   

© 2009 Akers Biosciences, Inc. All Rights Reserved.
Technical Services